Cresco Labs Stock News

Is Cresco a cannabis stock you should strongly consider? Here are two contrasting views.

Is Cresco a cannabis stock you should strongly consider? Here are two contrasting views.

Cresco Labs (OTCMKTS:CRLBF) had its price objective raised by Cantor Fitzgerald from $12.00 to $19.00 in a report released on Monday, The Fly reports. The brokerage presently has an overweight rating on the stock. Cantor Fitzgeralds target price points to a potential upside of 108.56% from the companys previous close. A number of other research []

A new bill introduced by a House Republican and strong earnings are causing big moves.

Cantor Fitzgerald maintained its rating of ‘Overweight' for Cresco Labs Inc (OTC:CRLBF) and raised its price target from $12 to $19, calling the stock a “top pick.”  Citing Cresco's positio

Cresco Labs Flagship Illinois Dispensary Opens Steps From Chicagos Wrigley Field Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco Labs or the Company), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the grand opening of its flagship Sunnyside dispensary, located 300 feet from the iconic Wrigley Field Marquee. A ceremonial ribbon cutting will take place this morning with elected officials, community leaders and Company executives. Sunnyside Wrigleyville is Cresco Labs flagship Illinois dispensary in Chicago. (Photo: Business Wire) This is a one-of-a-kind Sunnyside that will better accommodate our existing patients and consumers and act as a showcase for the millions of visitors to the Wrigleyville neighborhood each year. It will feature unique product activations, 21 points of sale and plenty of space to serve patients and customers on high-traffic days when baseball games, concerts and large-scale events are taking place next door, said Charlie Bachtell, Cresco Labs CEO & Co-founder. To think back on when the original Wrigleyville location opened for medical sales five years ago, its incredible to see how far this industry and organization has come and to see the outstanding execution from our retail team. Cresco Labs relocated its Sunnyside dispensary two blocks south to 3524 N.

Bargains still abound for opportunistic long-term investors.

Cresco Labs Inc. (OTCMKTS:CRLBF) has been given an average recommendation of Buy by the eight brokerages that are covering the stock, MarketBeat.com reports. Seven analysts have rated the stock with a buy rating. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $23.57. []

4 Marijuana Stocks To Watch In November The post Marijuana Stock 2021 Recap 4 Top Gainers For The 2nd Week Of November appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Bu

Are US Pot Stocks The Best Investments In Cannabis? The post Best Marijuana Stocks To Buy Right Now? 2 Top Tier US MSO For Your List Today appeared first on Marijuana Stocks | Cannabis Investments and

We have been bullish on Cresco Labs for a long time. Our enthusiasm is not waning. There is a lot of positivity in Cresco's new numbers.

Cresco Labs Inc. (CRLBF) CEO Charlie Bachtell on Q3 2021 Earnings Conference Call - Earnings Call Transcript

Vertically integrated cannabis company Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) announced its financial results Thursday for the third quarter ended September 30, 2021, reporting revenue of

Cresco Labs Inc. CRLBF, -1.09% said Thursday it lost $263.45 million in the third quarter after reporting net income of $25.58 million in the year-ago quarter. The cannabis company did not provide res

MSOS Looks Ready To Break Out